Funding
Main trial
The UKPDS cost 23 million pounds sterling (37 million US dollars). Funding was made available primarily by:
- UK Medical Research Council
- British Diabetic Association (Now Diabetes UK)
- UK Department of Health
- British Heart Foundation
- US National Institutes of Health (NEI, NIDDK)
- Wellcome Trust
- Novo-Nordisk
- Bayer
- Bristol-Myers Squibb
- Hoechst
- Lilly
- Lipha
- Glaxo Wellcome
- SmithKline Beecham
- Pfizer
- Zeneca
- Pharmacia & Upjohn
- Roche
- Farmitalia Carlo Erba
- Charles Wolfson Charitable Trust
- Clothworkers' Foundation
- Health Promotion Research Trust
- The Alan and Babette Sainsbury Trust
- The Oxford University Medical Research Fund Committee
ost trial monitoring
1997 to 2002
- UK Medical Research Council
- UK Department of Health
- Diabetes UK
- British Heart Foundation
- US National Institutes of Health (NEI, NIDDK)
